Can Eye Cells Predict TMS Success for Depression?
Part of Mental health clinical trials.
This study tests whether a specific type of eye cell can predict how well transcranial magnetic stimulation (TMS) works for treating depression. TMS is a non-invasive brain stimulation method that may help people with depression that hasn't responded to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of major depressive disorder (MDD) that is treatment-resistant (not getting better with standard treatments).
- You must be between 18 and 65 years old.
- Your vision must be good enough to see clearly (20/32 or better).
- You cannot have tried TMS therapy before.
- You cannot have other serious mental health conditions, eye diseases, or certain medical problems like diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at brain and heart-related measurements to predict who is most likely to improve with rTMS (repetitive transcranial magnetic stimulation) for depression. It may help future patients by identifying markers of treatment response.
This trial uses PET scans to see how transcranial magnetic stimulation (TMS) affects the brain in people whose depression hasn't improved with at least two different antidepressants. It aims to find markers that could predict who might benefit from TMS.
This study looks for early brain-wave patterns that could help personalize treatment for people with depression that hasn't responded to medication. Researchers will use brain imaging and a non-invasive brain stimulation technique to see if these patterns can predict who benefits most from treatment.
This trial is testing a type of brain stimulation therapy called theta-burst rTMS to see if it helps with depression that hasn't improved with standard treatments. It also uses brain scans to predict who might respond best.
This study tests how a specific kind of brain stimulation (repetitive transcranial magnetic stimulation) works for people with depression that has not responded to standard treatments. If you qualify, it may help doctors understand the mechanism and improve options for treatment-resistant depression.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
Hear when a new Depression - Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.